These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 30574145)
21. GYF-21, an epoxide 2‑(2‑phenethyl)‑chromone derivative, suppresses dysfunction of B cells mainly via inhibiting BAFF activated signaling pathways. Guo R; Li J; Gu Y; Li Y; Li S; Gao X; Zhu Z; Tu P Int Immunopharmacol; 2019 Feb; 67():473-482. PubMed ID: 30597293 [TBL] [Abstract][Full Text] [Related]
22. Toll-like receptor 9 activation enhances B cell activating factor and interleukin-21 induced anti-proteinase 3 autoantibody production in vitro. Lepse N; Land J; Rutgers A; Kallenberg CG; Stegeman CA; Abdulahad WH; Heeringa P Rheumatology (Oxford); 2016 Jan; 55(1):162-72. PubMed ID: 26320128 [TBL] [Abstract][Full Text] [Related]
23. B cell-activating factor (BAFF) from dendritic cells, monocytes and neutrophils is required for B cell maturation and autoantibody production in SLE-like autoimmune disease. Giordano D; Kuley R; Draves KE; Elkon KB; Giltiay NV; Clark EA Front Immunol; 2023; 14():1050528. PubMed ID: 36923413 [TBL] [Abstract][Full Text] [Related]
25. B cell activating factor, its role in autoimmunity, and targeting in autoimmune diseases. Krivosikova M; Dallos T; Maslinski W; Buc M Bratisl Lek Listy; 2009; 110(3):137-45. PubMed ID: 19507632 [TBL] [Abstract][Full Text] [Related]
26. BAFF neutralization impairs the autoantibody-mediated clearance of dead adipocytes and aggravates obesity-induced insulin resistance. Lempicki MD; Gray JA; Abuna G; Murata RM; Divanovic S; McNamara CA; Meher AK Front Immunol; 2024; 15():1436900. PubMed ID: 39185417 [TBL] [Abstract][Full Text] [Related]
27. Lack of T cells in Act1-deficient mice results in elevated IgM-specific autoantibodies but reduced lupus-like disease. Johnson AC; Davison LM; Giltiay NV; Vareechon C; Li X; Jørgensen TN Eur J Immunol; 2012 Jul; 42(7):1695-705. PubMed ID: 22585710 [TBL] [Abstract][Full Text] [Related]
28. B cell activating factor (BAFF) from neutrophils and dendritic cells is required for protective B cell responses against Salmonella typhimurium infection. Kuley R; Draves KE; Fuller DH; Giltiay NV; Clark EA; Giordano D PLoS One; 2021; 16(10):e0259158. PubMed ID: 34705890 [TBL] [Abstract][Full Text] [Related]
29. Global T cell dysregulation in non-autoimmune-prone mice promotes rapid development of BAFF-independent, systemic lupus erythematosus-like autoimmunity. Stohl W; Jacob N; Quinn WJ; Cancro MP; Gao H; Putterman C; Gao X; Pricop L; Koss MN J Immunol; 2008 Jul; 181(1):833-41. PubMed ID: 18566449 [TBL] [Abstract][Full Text] [Related]
30. Regulation of the B cell receptor repertoire and self-reactivity by BAFF. Ota M; Duong BH; Torkamani A; Doyle CM; Gavin AL; Ota T; Nemazee D J Immunol; 2010 Oct; 185(7):4128-36. PubMed ID: 20817867 [TBL] [Abstract][Full Text] [Related]
31. Functional and clinical aspects of the B-cell-activating factor (BAFF): a narrative review. Lied GA; Berstad A Scand J Immunol; 2011 Jan; 73(1):1-7. PubMed ID: 21128997 [TBL] [Abstract][Full Text] [Related]
32. BAFF Produced by Neutrophils and Dendritic Cells Is Regulated Differently and Has Distinct Roles in Antibody Responses and Protective Immunity against West Nile Virus. Giordano D; Kuley R; Draves KE; Roe K; Holder U; Giltiay NV; Clark EA J Immunol; 2020 Mar; 204(6):1508-1520. PubMed ID: 32034064 [TBL] [Abstract][Full Text] [Related]
33. Rescue of the mature B cell compartment in BAFF-deficient mice by treatment with recombinant Fc-BAFF. Swee LK; Tardivel A; Schneider P; Rolink A Immunol Lett; 2010 Jun; 131(1):40-8. PubMed ID: 20350570 [TBL] [Abstract][Full Text] [Related]
34. Povetacicept, an Enhanced Dual APRIL/BAFF Antagonist That Modulates B Lymphocytes and Pathogenic Autoantibodies for the Treatment of Lupus and Other B Cell-Related Autoimmune Diseases. Evans LS; Lewis KE; DeMonte D; Bhandari JG; Garrett LB; Kuijper JL; Ardourel D; Wolfson MF; Debrot S; Mudri S; Kleist K; Griffin LL; Hebb L; Sanderson RJ; Wang N; Seaberg M; Chunyk AG; Yang J; Hong Y; Maria Z; Messenheimer DJ; Holland PM; Peng SL; Rixon MW; Dillon SR Arthritis Rheumatol; 2023 Jul; 75(7):1187-1202. PubMed ID: 36705554 [TBL] [Abstract][Full Text] [Related]
35. Cutting Edge: BAFF Promotes Autoantibody Production via TACI-Dependent Activation of Transitional B Cells. Jacobs HM; Thouvenel CD; Leach S; Arkatkar T; Metzler G; Scharping NE; Kolhatkar NS; Rawlings DJ; Jackson SW J Immunol; 2016 May; 196(9):3525-31. PubMed ID: 27022196 [TBL] [Abstract][Full Text] [Related]
36. The function of BAFF on T helper cells in autoimmunity. Chen M; Lin X; Liu Y; Li Q; Deng Y; Liu Z; Brand D; Guo Z; He X; Ryffel B; Zheng SG Cytokine Growth Factor Rev; 2014 Jun; 25(3):301-5. PubMed ID: 24411564 [TBL] [Abstract][Full Text] [Related]
37. B cell activating factor inhibition impairs bacterial immunity by reducing T cell-independent IgM secretion. Jones DD; Jones M; DeIulio GA; Racine R; MacNamara KC; Winslow GM Infect Immun; 2013 Dec; 81(12):4490-7. PubMed ID: 24082070 [TBL] [Abstract][Full Text] [Related]
38. BAFF regulates activation of self-reactive T cells through B-cell dependent mechanisms and mediates protection in NOD mice. Mariño E; Walters SN; Villanueva JE; Richards JL; Mackay CR; Grey ST Eur J Immunol; 2014 Apr; 44(4):983-93. PubMed ID: 24435807 [TBL] [Abstract][Full Text] [Related]
39. In vitro and in vivo activation induces BAFF and APRIL expression in B cells. Chu VT; Enghard P; Riemekasten G; Berek C J Immunol; 2007 Nov; 179(9):5947-57. PubMed ID: 17947668 [TBL] [Abstract][Full Text] [Related]